Low levels of mannan binding protein (MBP) may protect against rheumat
oid arthritis and other inflammatory conditions associated with agalac
tosyl IgG. MBP concentrations were measured in 99 sera found to be pos
itive for rheumatoid factor, at least 41 of which were from patients w
ith rheumatoid arthritis, and the values compared to the data from 352
controls. MBP was undetectable in similar proportions of patients' an
d control sera (4.0 and 4.3%, respectively), and low values generally
were similarly distributed in the two groups. Overall, however, the pa
tient values were distorted upwards relative to controls, consistent w
ith an acute-phase response. These findings do not refute the proposed
role for MBP-agalactosyl IgG-mediated complement activation in the pa
thogenesis of rheumatoid arthritis, but certainly provide no support f
or that hypothesis.